Latest filing published 04 May 2023 for GeneDx Holdings Corp..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Rachel E. Sherman: trading record in brief
Rachel E. Sherman, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in GeneDx Holdings Corp. and Aptinyx Inc. In total, 3 filings cover trades dated from 22 January 2020 to 2 May 2023.
On the market, this insider has only ever bought: 1 purchase, €9,394 in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 option exercises.
The latest filing, published on 4 May 2023, reports an option exercise in GeneDx Holdings Corp. The latest purchase dates back some time: it was published 2,481 days ago, on 23 January 2020. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Rachel E. Sherman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 45,454 shares0Class A Common StockSEC:0001209191-23-027339:0
- 12,836 sharesClass A Common StockSEC:0001209191-22-028696:0
2 of 2 declarations
